| Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase. | |
| | |
MedLine Citation:
|
PMID: 18981171 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The UDP glycosyltransferases (UGT) attach sugar residues to small lipophilic chemicals to alter their biological properties and enhance elimination. Of the four families present in mammals, two families, UGT1 and UGT2, use UDP glucuronic acid to glucuronidate bilirubin, steroids, bile acids, drugs, and many other endogenous chemicals and xenobiotics. UGT8, in contrast, uses UDP galactose to galactosidate ceramide, an important step in the synthesis of glycosphingolipids and cerebrosides. The function of the fourth family, UGT3, is unknown. Here we report the cloning, expression, and functional characterization of UGT3A1. This enzyme catalyzes the transfer of N-acetylglucosamine from UDP N-acetylglucosamine to ursodeoxycholic acid (3alpha, 7beta-dihydroxy-5beta-cholanoic acid). The enzyme uses ursodeoxycholic acid and UDP N-acetylglucosamine in preference to other primary and secondary bile acids, and other UDP sugars such as UDP glucose, UDP glucuronic acid, UDP galactose, and UDP xylose. In addition to ursodeoxycholic acid, UGT3A1 has activity toward 17alpha-estradiol, 17beta-estradiol, and the prototypic substrates of the UGT1 and UGT2 forms, 4-nitrophenol and 1-naphthol. A polymorphic UGT3A1 variant containing a C121G substitution was catalytically inactive. UGT3A1 is found in the liver and kidney, and to a lesser, in the gastrointestinal tract. These data describe the first characterization of a member of the UGT3 family. Its activity and distribution suggest that UGT3A1 may have an important role in the metabolism and elimination of ursodeoxycholic acid in therapies for ameliorating the symptoms of cholestasis or for dissolving gallstones. |
| | |
Authors:
|
Peter I Mackenzie; Anne Rogers; Joanna Treloar; Bo R Jorgensen; John O Miners; Robyn Meech |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2008-11-03 |
Journal Detail:
|
Title: The Journal of biological chemistry Volume: 283 ISSN: 0021-9258 ISO Abbreviation: J. Biol. Chem. Publication Date: 2008 Dec |
Date Detail:
|
Created Date: 2008-12-22 Completed Date: 2009-03-13 Revised Date: 2010-09-21 |
Medline Journal Info:
|
Nlm Unique ID: 2985121R Medline TA: J Biol Chem Country: United States |
Other Details:
|
Languages: eng Pagination: 36205-10 Citation Subset: IM |
Affiliation:
|
Department of Clinical Pharmacology, Flinders University School of Medicine, Flinders Medical Centre, Bedford Park, SA 5042, Australia. Peter.Mackenzie@flinders.edu.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amino Acid Sequence Cell Line Cholestasis Cloning, Molecular Glucose / chemistry Glucuronosyltransferase / chemistry, metabolism* Humans Kidney / enzymology Kinetics Liver / enzymology Models, Biological Molecular Sequence Data N-Acetylglucosaminyltransferases / chemistry*, metabolism Sequence Homology, Amino Acid Uridine Diphosphate / chemistry* Ursodeoxycholic Acid / metabolism |
| Chemical | |
Reg. No./Substance:
|
128-13-2/Ursodeoxycholic Acid; 50-99-7/Glucose; 58-98-0/Uridine Diphosphate; EC 2.4.1.-/N-Acetylglucosaminyltransferases; EC 2.4.1.-/UGT3A1 protein, human; EC 2.4.1.17/Glucuronosyltransferase |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Epidemiology and costs associated with genital warts in Canada.
Next Document: Glutamate acting on N-methyl-D-aspartate receptors attenuates insulin-like growth factor-1 receptor ...